75 related articles for article (PubMed ID: 29520517)
1. Initial treatment with pulse methylprednisolone followed by short-term prednisolone and tonsillectomy for childhood IgA nephropathy.
Yamada A; Fujinaga S; Sakuraya K; Satoshi A; Hirano D
Clin Exp Nephrol; 2018 Oct; 22(5):1143-1149. PubMed ID: 29520517
[TBL] [Abstract][Full Text] [Related]
2. Successful therapy with tonsillectomy plus pulse therapy for the relapse of pediatric IgA nephropathy treated with multi-drugs combination therapy.
Sakai N; Kawasaki Y; Waragai T; Oikawa T; Kaneko M; Sato T; Suyama K; Hosoya M
Fukushima J Med Sci; 2016 Jun; 62(1):68-73. PubMed ID: 27210310
[TBL] [Abstract][Full Text] [Related]
3. Tonsillectomy reduces recurrence of IgA nephropathy in mesangial hypercellularity type categorized by the Oxford classification.
Hirano K; Amano H; Kawamura T; Watanabe K; Koike K; Shimizu A; Endo S; Tsuboi N; Okonogi H; Miyazaki Y; Ikeda M; Hanaoka K; Ogura M; Komatsumoto S; Yokoo T
Clin Exp Nephrol; 2016 Jun; 20(3):425-32. PubMed ID: 26415960
[TBL] [Abstract][Full Text] [Related]
4. Initial treatment with tonsillectomy combined with intravenous methylprednisolone pulse - another option for Japanese children with severe nephrotic IgA vasculitis with nephritis.
Fujinaga S; Saito K
Pediatr Nephrol; 2024 May; 39(5):1671-1672. PubMed ID: 37934271
[No Abstract] [Full Text] [Related]
5. Nationwide survey on current treatments for IgA nephropathy in Japan.
Matsuzaki K; Suzuki Y; Nakata J; Sakamoto N; Horikoshi S; Kawamura T; Matsuo S; Tomino Y
Clin Exp Nephrol; 2013 Dec; 17(6):827-33. PubMed ID: 23519367
[TBL] [Abstract][Full Text] [Related]
6. Tonsillectomy combined with intravenous methylprednisolone pulse for Japanese children with severe IgA vasculitis with nephritis-authors' reply.
Horinouchi T; Nagai S; Nozu K
Pediatr Nephrol; 2024 May; 39(5):1673. PubMed ID: 38224374
[No Abstract] [Full Text] [Related]
7. Tonsillectomy Monotherapy for IgA Nephropathy: A Case Series.
Marumoto H; Tsuboi N; Kawamura T; Yokoo T
Kidney Med; 2020; 2(5):620-628. PubMed ID: 33089140
[TBL] [Abstract][Full Text] [Related]
8. A pediatric case of IgA nephropathy benefitting from targeted release formulation-budesonide.
Antonucci L; Colucci M; Emma F; Vivarelli M
Pediatr Nephrol; 2023 Nov; 38(11):3849-3852. PubMed ID: 37041389
[TBL] [Abstract][Full Text] [Related]
9. A case of immunoglobulin A nephropathy treated successfully with tonsillectomy and steroid pulse therapy 20 years after onset.
Hasegawa J; Yamada K; Kaga Y; Abe Y; Endo M; Wakai S
CEN Case Rep; 2014 May; 3(1):30-33. PubMed ID: 28509243
[TBL] [Abstract][Full Text] [Related]
10. Long-term Outcomes after Steroid Pulse Therapy in Patients with Type 1 Autoimmune Pancreatitis.
Ikeura T; Tomiyama T; Takaori A; Ito T; Nakamaru K; Masuda M; Hori Y; Tsukuda S; Sumimoto K; Mitsuyama T; Nakayama S; Shimatani M; Uchida K; Takaoka M; Okazaki K; Naganuma M
Intern Med; 2023 Oct; 62(20):2931-2940. PubMed ID: 36889699
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroids in the treatment of IgA nephropathy: lessons from the TESTING trial.
Zhang Y; Hu YT; Lv JC; Zhang H
Pediatr Nephrol; 2023 Oct; 38(10):3211-3220. PubMed ID: 36881171
[TBL] [Abstract][Full Text] [Related]
12. Associations of corticosteroid therapy and tonsillectomy with kidney survival in a multicenter prospective study for IgA nephropathy.
Kawamura T; Hirano K; Koike K; Nishikawa M; Shimizu A; Joh K; Katafuchi R; Hashiguchi A; Matsuzaki K; Maruyama S; Tsuboi N; Narita I; Yano Y; Yokoo T; Suzuki Y
Sci Rep; 2023 Oct; 13(1):18455. PubMed ID: 37891208
[TBL] [Abstract][Full Text] [Related]
13. Differences in response to treatment in children with severe IgA nephropathy according to patient age.
Kawasaki Y; Kume Y; Ono A; Maeda R; Go H
Fukushima J Med Sci; 2023 Aug; 69(2):125-132. PubMed ID: 37164762
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the clinical efficacy of tonsillectomy with steroid pulse therapy and tonsillectomy therapy alone for patients with immunoglobulin A nephropathy: a retrospective observational study.
Sato R; Wakisaka R; Komatsuda H; Yamaki H; Ohara K; Kumai T; Kishibe K; Nakagawa N; Hayashi T; Takahara M
Clin Exp Nephrol; 2024 Jun; ():. PubMed ID: 38888720
[TBL] [Abstract][Full Text] [Related]
15. Pulse Methylprednisolone with Oral Prednisolone versus Adrenocorticotropic Hormone in Children with West Syndrome: a Randomized Controlled Trial.
Fatema K; Rahman M; Hossain MM; Akhter S; Shomee DA; Akhter S; Mannan M
J Epilepsy Res; 2021 Dec; 11(2):136-141. PubMed ID: 35087722
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of drug-induced autoimmune-like hepatitis after pulse steroid therapy.
Ueno M; Takabatake H; Kayahara T; Morimoto Y; Notohara K; Mizuno M
Hepatol Res; 2023 Nov; 53(11):1073-1083. PubMed ID: 37347239
[TBL] [Abstract][Full Text] [Related]
17. Methylprednisolone intravenous pulse therapy for pediatric patients with post-infectious bronchiolitis obliterans: an update.
Tomikawa SO; Rodrigues JC; Nakaie CMA; Silva Filho LVRFD
J Bras Pneumol; 2024 May; 50(2):e20230373. PubMed ID: 38747815
[No Abstract] [Full Text] [Related]
18. Efficacy and Safety of Pulse Intravenous Methylprednisolone in Pediatric Epileptic Encephalopathies: Timing and Networks Consideration.
Russo A; Mazzone S; Landolina L; Colucci R; Baccari F; Fetta A; Boni A; Cordelli DM
J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731025
[No Abstract] [Full Text] [Related]
19. Preventive Effect of Tonsillectomy on Recurrence of Henoch-Schönlein Purpura Nephritis after Intravenous Methylprednisolone Pulse Therapy.
Umeda C; Fujinaga S; Endo A; Sakuraya K; Asanuma S; Hirano D
Tohoku J Exp Med; 2020 Jan; 250(1):61-69. PubMed ID: 31996498
[TBL] [Abstract][Full Text] [Related]
20. Clinical Efficacy of Huangkui Capsule Plus Methylprednisolone for Immunoglobulin A Nephropathy and Its Effect on Renal Function and Serum Inflammatory Factors.
Yuan L; Cai K; Zou Y
Evid Based Complement Alternat Med; 2023; 2023():3020033. PubMed ID: 36865740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
